title: M(2)-β(2) interaction: a basis for combined bronchodilator treatment.
authors.forename: José Luis
authors.initials: JL
authors.lastname: López-Campos
mesh_terms: D000262:Adenylyl Cyclases / Q000378:metabolism; D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D020013:Calcium Signaling / Q000502:physiology; D000242:Cyclic AMP / Q000502:physiology; D004334:Drug Administration Schedule; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D009130:Muscle, Smooth / Q000187:drug effects / Q000503:physiopathology; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D043585:Receptor, Muscarinic M2 / Q000502:physiology; D043587:Receptor, Muscarinic M3 / Q000037:antagonists & inhibitors; D018343:Receptors, Adrenergic, beta-2 / Q000502:physiology; D012602:Scopolamine Derivatives / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D015290:Second Messenger Systems / Q000502:physiology; D000069447:Tiotropium Bromide
chemical_list: D058666:Adrenergic beta-2 Receptor Agonists; D001993:Bronchodilator Agents; D018727:Muscarinic Antagonists; D043585:Receptor, Muscarinic M2; D043587:Receptor, Muscarinic M3; D018343:Receptors, Adrenergic, beta-2; D012602:Scopolamine Derivatives; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D000069447:Tiotropium Bromide